Onset and Duration of Symptoms of Loss of Smell/taste in Patients with COVID-19: A Systematic Review

Overview

Journal Am J Otolaryngol

Specialty Otorhinolaryngology

Date 2021 Jan 14

PMID 33445036

Citations 55

Authors

Renata Emmanuele Assuncao Santos

Maria Giselda da Silva

Maria Caroline Barbosa do Monte Silva

Danielly Alves Mendes Barbosa

Ana Lisa do Vale Gomes

Ligia Cristina Monteiro Galindo

Raquel Da Silva Aragao

Kelli Nogueira Ferraz-Pereira

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of the study was to conduct a systematic review of the literature to investigate the time of onset and duration of symptoms of loss of smell and taste in patients diagnosed with COVID-19.

Methods: Two independent authors performed a systematic review of the Medline/PubMed, SCOPUS, COCHRANE, Lilacs and Web of Science electronic databases. The time of onset and duration of symptoms were considered primary outcomes. The sex and age of individuals, the geographical location of the study, the prevalence of symptoms, other associated symptoms, associated comorbidities, and the impact on quality of life and eating habits were considered secondary outcomes.

Results: Our search generated 17 articles. Many of the studies reported that the onset of anosmia and ageusia occurred 4 to 5 days after the manifestation of other symptoms of the infection and that these symptoms started to disappear after one week, with more significant improvements in the first two weeks.

Conclusion: The present study concludes that the onset of symptoms of loss of smell and taste, associated with COVID-19, occurs 4 to 5 days after other symptoms, and that these symptoms last from 7 to 14 days. Findings, however, varied and there is therefore a need for further studies to clarify the occurrence of these symptoms. This would help to provide early diagnosis and reduce contagion by the virus.

Citing Articles

Histopathology of the tongue in a hamster model of COVID-19.

Coggins J, Saito M, Cook R, Urata S, Urata M, Harsell N BMC Oral Health. 2025; 25(1):121.

PMID: 39849469 PMC: 11755867. DOI: 10.1186/s12903-025-05420-9.

No lasting impact of Covid-19 on the auditory system: a prospective cohort study.

Hassani S, Lazem M, Jafari Z J Laryngol Otol. 2024; 135(12):1063-1068.

PMID: 39658938 PMC: 8576134. DOI: 10.1017/S002221512100267X.

Polyunsaturated Fatty Acids as Potential Treatments for COVID-19-Induced Anosmia.

Wang Y, Lin C, Huang C Biomedicines. 2024; 12(9).

PMID: 39335598 PMC: 11428228. DOI: 10.3390/biomedicines12092085.

Determining the sweet detection threshold of COVID-19 patients during infection and recovery periods.

Alsanei W, Alhussin E, Natto Z, Afeef M, Aktar T PLoS One. 2024; 19(8):e0309342.

PMID: 39208140 PMC: 11361598. DOI: 10.1371/journal.pone.0309342.

Histopathology of the Tongue in a Hamster Model of COVID-19.

Coggins J, Saito M, Cook R, Urata S, Urata M, Harsell N Res Sq. 2024; .

PMID: 39011098 PMC: 11247945. DOI: 10.21203/rs.3.rs-4590482/v1.

References

Lechien J, Chiesa-Estomba C, De Siati D, Horoi M, Le Bon S, Rodriguez A . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8):2251-2261. PMC: 7134551. DOI: 10.1007/s00405-020-05965-1. View

Hopkins C, Surda P, Kumar N . Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology. 2020; 58(3):295-298. DOI: 10.4193/Rhin20.116. View

Izquierdo-Dominguez A, Rojas-Lechuga M, Mullol J, Alobid I . Olfactory Dysfunction in the COVID-19 Outbreak. J Investig Allergol Clin Immunol. 2020; 30(5):317-326. DOI: 10.18176/jiaci.0567. View

Roland L, Gurrola 2nd J, Loftus P, Cheung S, Chang J . Smell and taste symptom-based predictive model for COVID-19 diagnosis. Int Forum Allergy Rhinol. 2020; 10(7):832-838. PMC: 7267242. DOI: 10.1002/alr.22602. View

Parma V, Ohla K, Veldhuizen M, Niv M, Kelly C, Bakke A . More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis. Chem Senses. 2020; 45(7):609-622. PMC: 7337664. DOI: 10.1093/chemse/bjaa041. View

Jotz G, Voegels R, Bento R . Otorhinolaryngologists and Coronavirus Disease 2019 (COVID-19). Int Arch Otorhinolaryngol. 2020; 24(2):e125-e128. PMC: 7153919. DOI: 10.1055/s-0040-1709724. View

Wee L, Chan Y, Teo N, Cherng B, Thien S, Wong H . The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19. Eur Arch Otorhinolaryngol. 2020; 277(8):2389-2390. PMC: 7180656. DOI: 10.1007/s00405-020-05999-5. View

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-513. PMC: 7135076. DOI: 10.1016/S0140-6736(20)30211-7. View

Zhang Q, Shan K, Abdollahi S, Nace T . Anosmia and Ageusia as the Only Indicators of Coronavirus Disease 2019 (COVID-19). Cureus. 2020; 12(5):e7918. PMC: 7263711. DOI: 10.7759/cureus.7918. View

10.

Suliburska J, Duda G, Pupek-Musialik D . The influence of hypotensive drugs on the taste sensitivity in patients with primary hypertension. Acta Pol Pharm. 2012; 69(1):121-7. View

11.

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q . Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6):683-690. PMC: 7149362. DOI: 10.1001/jamaneurol.2020.1127. View

12.

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

13.

Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L . Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020; 71(15):889-890. PMC: 7184514. DOI: 10.1093/cid/ciaa330. View

14.

Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry B . Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis (Berl). 2020; 7(2):91-96. DOI: 10.1515/dx-2020-0046. View

15.

Guner R, Hasanoglu I, Aktas F . COVID-19: Prevention and control measures in community. Turk J Med Sci. 2020; 50(SI-1):571-577. PMC: 7195988. DOI: 10.3906/sag-2004-146. View

16.

Phan T . Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 2020; 81:104260. PMC: 7106203. DOI: 10.1016/j.meegid.2020.104260. View

17.

Klopfenstein T, Kadiane-Oussou N, Toko L, Royer P, Lepiller Q, Gendrin V . Features of anosmia in COVID-19. Med Mal Infect. 2020; 50(5):436-439. PMC: 7162775. DOI: 10.1016/j.medmal.2020.04.006. View

18.

Gautier J, Ravussin Y . A New Symptom of COVID-19: Loss of Taste and Smell. Obesity (Silver Spring). 2020; 28(5):848. PMC: 7228286. DOI: 10.1002/oby.22809. View

19.

Vaira L, Deiana G, Fois A, Pirina P, Madeddu G, De Vito A . Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 2020; 42(6):1252-1258. PMC: 7267244. DOI: 10.1002/hed.26204. View

20.

Kershaw J, Mattes R . Nutrition and taste and smell dysfunction. World J Otorhinolaryngol Head Neck Surg. 2018; 4(1):3-10. PMC: 6051307. DOI: 10.1016/j.wjorl.2018.02.006. View